YY1/BCCIP Coordinately Regulates P53-Responsive Element (p53RE)-Mediated Transactivation of p21Waf1/Cip1

Transactivation of p21 (cyclin-dependent kinase inhibitor 1A, CDKN1A) is closely related to the recruitment of transcription cofactors at the p53 responsive elements (p53REs) in its promoter region. Human chromatin remodeling enzyme INO80 can be recruited to the p53REs of p21 promoter and negatively regulates p21. As one of the key subunits of the INO80 complex, YY1 has also been confirmed to bind to the p53RE sites of p21 promoter. Importantly, YY1 was recently reported to be bound and stabilized by BCCIP (BRCA2 and CDKN1A-interacting protein). Therefore, we hypothesized that the YY1/BCCIP complex plays an important role in regulating the transactivation of p21. Here we present evidence that the YY1/BCCIP complex coordinatively regulates p53RE-mediated p21 transactivation. We first confirmed the cross-interaction between YY1, BCCIP, and p53, suggesting an intrinsic link between three proteins in the regulation of p21 transcription. In dual luciferase assays, YY1 inhibited p53RE-mediated luciferase activity, whereas BCCIP revealed the opposite effect. More interestingly, the region 146–270 amino acids of YY1, which bound to BCCIP, increased p53-mediated luciferase activity, indicating the complexity of the YY1/BCCIP complex in co-regulating p21 transcription. Further in-depth research confirmed the co-occupancy of YY1/BCCIP with p53 at the p53RE-proximal region of p21. Lentiviral-mediated knockdown of BCCIP inhibited the recruitment of p53 and YY1 at the p53RE proximal region of p21; however, this phenomenon was reversed by expressing exogenous YY1, suggesting the collaborative regulation of YY1/BCCIP complex in p53RE-mediated p21 transcription. These data provide new insights into the transcriptional regulation of p21 by the YY1/BCCIP complex.

[1]  N. Cruickshanks,et al.  The p53 Pathway in Glioblastoma , 2018, Cancers.

[2]  Hongjie Yao,et al.  The chromatin remodeling protein INO80 contributes to the removal of H2A.Z at the p53‐binding site of the p21 gene in response to doxorubicin , 2018, The FEBS journal.

[3]  Fuqiang Li,et al.  BCCIP binds to and activates its promoter in a YY1‐dependent fashion in HCT116 cells , 2018, The FEBS journal.

[4]  A. Strasser,et al.  How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? , 2018 .

[5]  Doo Sin Jo,et al.  Up-regulation of UVRAG by HDAC1 Inhibition Attenuates 5FU-induced Cell Death in HCT116 Colorectal Cancer Cells. , 2018, Anticancer research.

[6]  A. Strasser,et al.  How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? , 2017, Cell Death and Differentiation.

[7]  Fuqiang Li,et al.  Human INO80/YY1 chromatin remodeling complex transcriptionally regulates the BRCA2- and CDKN1A-interacting protein (BCCIP) in cells , 2016, Protein & Cell.

[8]  Fei Wang,et al.  Negative Regulation of p21Waf1/Cip1 by Human INO80 Chromatin Remodeling Complex Is Implicated in Cell Cycle Phase G2/M Arrest and Abnormal Chromosome Stability , 2015, PloS one.

[9]  L. Attardi,et al.  Unravelling mechanisms of p53-mediated tumour suppression , 2014, Nature Reviews Cancer.

[10]  Wei Gu,et al.  Understanding the non-canonical pathways involved in p53-mediated tumor suppression. , 2014, Carcinogenesis.

[11]  G. Del Sal,et al.  Autophosphorylation and Pin1 binding coordinate DNA damage-induced HIPK2 activation and cell death , 2013, Proceedings of the National Academy of Sciences.

[12]  L. Attardi,et al.  p53 at a glance , 2010, Journal of Cell Science.

[13]  M. Washburn,et al.  YY1 functions with INO80 to activate transcription , 2007, Nature Structural &Molecular Biology.

[14]  Zhiyuan Shen,et al.  Abrogation of the Transactivation Activity of p53 by BCCIP Down-regulation* , 2007, Journal of Biological Chemistry.

[15]  A. Efeyan,et al.  Tumour biology: Policing of oncogene activity by p53 , 2006, Nature.

[16]  M. Bucan,et al.  Promoter features related to tissue specificity as measured by Shannon entropy , 2005, Genome Biology.

[17]  Zhiyuan Shen,et al.  BCCIP Functions through p53 to Regulate the Expression of p21Waf1/Cip1 , 2004, Cell cycle.

[18]  S. Grossman,et al.  Yin Yang 1 Is a Negative Regulator of p53 , 2004, Cell.

[19]  T. Ekström,et al.  YY1 binding to a subset of p53 DNA-target sites regulates p53-dependent transcription. , 2004, Biochemical and biophysical research communications.

[20]  Yoshiharu Kawaguchi,et al.  MDM2–HDAC1‐mediated deacetylation of p53 is required for its degradation , 2002, The EMBO journal.

[21]  Ya-Li Yao,et al.  Regulation of Transcription Factor YY1 by Acetylation and Deacetylation , 2001, Molecular and Cellular Biology.

[22]  Yuan Yuan,et al.  Inhibition of breast and brain cancer cell growth by BCCIPα, an evolutionarily conserved nuclear protein that interacts with BRCA2 , 2001, Oncogene.

[23]  G. Pasz-Walczak,et al.  P21 (WAF1) expression in colorectal cancer: correlation with P53 and cyclin D1 expression, clinicopathological parameters and prognosis. , 2001, Pathology, research and practice.

[24]  K. Vousden,et al.  Minireviewp 53 : Death Star able to induce the defensive p 53 response to oncogene , 2000 .

[25]  S. Iguchi-Ariga,et al.  TOK-1, a Novel p21Cip1-binding Protein That Cooperatively Enhances p21-dependent Inhibitory Activity toward CDK2 Kinase* , 2000, The Journal of Biological Chemistry.

[26]  E. Seto,et al.  Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? , 1999, Gene.

[27]  Jeng-Shin Lee,et al.  Everything you have ever wanted to know about Yin Yang 1...... , 1997, Biochimica et biophysica acta.

[28]  J. Chuang,et al.  Transcriptional Regulation by p53 , 1995, The Journal of Biological Chemistry.

[29]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[30]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.